UTHR insider trading

SEC Form 4 transactions reported by United Therapeutics Corporation insiders, officers, directors, and 10%+ beneficial owners. Sourced from EDGAR.

Want this data via API instead of reading about it? Get a free API key →

Recent UTHR insider transactions

The 20 most recent non-derivative Form 4 transactions reported by United Therapeutics Corporation insiders. Buys are highlighted; the transaction code column matches SEC Form 4 codes (P = open-market purchase, S = sale, A = grant, M = option exercise, F = tax withholding).

Date Code Insider Role Shares Price Value
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 1,953 $497 $971K
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 599 $493 $295K
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 332 $499 $166K
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 2,182 $496 $1.1M
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 160 $502 $80K
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 468 $500 $234K
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 1,905 $495 $943K
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 1,750 $494 $865K
2026-09-17 S ROTHBLATT MARTINE A Chairperson & CEO, Director 151 $498 $75K
2026-09-17 M ROTHBLATT MARTINE A Chairperson & CEO, Director 9,500 $118 $1.1M
2026-09-17 S MAHON PAUL A EVP & GENERAL COUNSEL 1,160 $500 $580K
2026-09-17 S MAHON PAUL A EVP & GENERAL COUNSEL 125 $501 $63K
2026-09-17 S MAHON PAUL A EVP & GENERAL COUNSEL 1,400 $498 $697K
2026-09-17 M MAHON PAUL A EVP & GENERAL COUNSEL 8,300 $146 $1.2M
2026-09-17 S MAHON PAUL A EVP & GENERAL COUNSEL 843 $499 $420K
2026-09-17 S MAHON PAUL A EVP & GENERAL COUNSEL 320 $502 $161K
2026-09-17 S MAHON PAUL A EVP & GENERAL COUNSEL 1,579 $496 $783K
2026-09-17 S MAHON PAUL A EVP & GENERAL COUNSEL 2,873 $497 $1.4M
2026-09-16 S ROTHBLATT MARTINE A Chairperson & CEO, Director 1,220 $499 $609K
2026-09-16 M ROTHBLATT MARTINE A Chairperson & CEO, Director 9,500 $118 $1.1M

What insider trading data covers for UTHR

United Therapeutics Corporation (CIK 1082554) reports Section 16 insider transactions on Form 4 within two business days. Each filing carries the transaction date, transaction code (P for open-market purchase, S for sale, M for option exercise, F for tax withholding), shares, price, and post-transaction holdings. Optional footnotes disclose Rule 10b5-1 plan references and indirect ownership relationships.

How to interpret UTHR insider activity

Treat each filing line through three filters: the transaction code, the role of the filer (officer carries more signal than director), and the dollar value relative to the company's market cap. Open-market purchases (P) by C-suite officers carry the strongest bullish signal. Sales (S) referencing a Rule 10b5-1 plan in the footnotes are pre-arranged and should be discounted. See how to read a Form 4 for the full walkthrough.

Get UTHR insider data via API

Pull recent UTHR Form 4 filings, filtered to open-market purchases above $100k:

curl "https://api.edgarkit.com/v1/filings?ticker=UTHR&form_type=4&transaction_code=P&min_value=100000&limit=20" \
  -H "Authorization: Bearer YOUR_API_KEY"

Subscribe via webhook to receive every new UTHR Form 4 in real time:

curl -X POST "https://api.edgarkit.com/v1/webhooks" \
  -H "Authorization: Bearer YOUR_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "url": "https://your-server.com/edgarkit-events",
    "filters": {"form_types": ["4"], "tickers": ["UTHR"]}
  }'

Cluster buying detection for UTHR

The strongest insider signal at the issuer level is cluster buying: three or more distinct insiders placing open-market purchases within a 7-14 day window. For the complete pattern detector, see how to detect insider cluster buying.